Search

everythinglearnresearchcommunity

for

Search:↓

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Rabies virus was found in specific skin cells of rabid dogs' muzzles, suggesting these cells could help diagnose rabies.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

The visfatin GT genotype may increase the risk of Alopecia Areata.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Targeting regulatory T cells may help treat age-related diseases.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Transplant success has improved with better immunosuppressive drugs and donor matching.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.

Major histocompatibility antigens are found in specific skin cells and structures, but not in sweat glands.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.